05/07/2026
Let’s Clear This Up: There is NO such thing as “GLP-3” !!
We’re seeing a lot of misinformation circulating, so let’s set the record straight…
There is no medication or hormone class called “GLP-3.” This term is being incorrectly used, often to market or describe Retatrutide (“Reta”).
Here’s the truth:
✔️ Retatrutide is a triple hormone receptor agonist (GLP-1, GIP, and glucagon receptors)
✔️It is currently in clinical trials
✔️ It is NOT FDA-approved at this time
✔️ It has NOT been released by the manufacturer for public use
What is a hormone receptor agonist?
It is a substance (drug or neurotransmitter) that binds to a cell receptor and activates it, producing a biological response that mimics a natural substance.
So what does that mean?
If something is being sold or advertised right now as “Retatrutide” or “GLP-3”… it is not legitimate, FDA-approved Retatrutide.
As healthcare professionals, safety and transparency matter. Medications that are still in clinical trials have not yet been proven safe or effective for public use, and sourcing them outside of approved channels carries serious risks.
💉 Stay informed.
💉 Ask questions.
💉 Protect your health.
If you’re ever unsure about what you’re being offered, we’re always here to help guide you.
Attached is a link directly to the true and only manufacturer of Retatrutide(Reta)…
https://www.lilly.com/news/stories/what-to-know-about-retatrutide
Please stay informed and do your research before purchasing and injecting yourself with unknown substances from unknown sources. If you were in a true clinical trial it would be through the manufacturer of that drug with many follow up appointments.
With care,
2Salty Nurses
*We are not sponsored by, affiliated with, or financially connected to this brand. We simply just care.
💗💗💗💗💗💗💗💗💗💗💗💗💗💗
Frequently asked questions and answers about Lilly’s retatrutide, an investigational, once-weekly injectable medication that is being studied for the treatment of obesity.
